BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Treatment
470 results:

  • 1. Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-bcl2 micelleplexes.
    De A; Kang JH; Sauraj ; Lee OH; Ko YT
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130783. PubMed ID: 38471603
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
    Hediyal TA; Vichitra C; Anand N; Bhaskaran M; Essa SM; Kumar P; Qoronfleh MW; Akbar M; Kaul-Ghanekar R; Mahalakshmi AM; Yang J; Song BJ; Monaghan TM; Sakharkar MK; Chidambaram SB
    Front Immunol; 2024; 15():1324018. PubMed ID: 38449863
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
    Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
    Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
    Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
    BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.
    Reisbeck L; Linder B; Tascher G; Bozkurt S; Weber KJ; Herold-Mende C; van Wijk SJL; Marschalek R; Schaefer L; Münch C; Kögel D
    Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1451-C1469. PubMed ID: 37899749
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance.
    Fitzgerald MC; O'Halloran PJ; Kerrane SA; Ní Chonghaile T; Connolly NMC; Murphy BM
    Cell Death Dis; 2023 Oct; 14(10):705. PubMed ID: 37898609
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.
    Haikazian S; Chen-Li DCJ; Johnson DE; Fancy F; Levinta A; Husain MI; Mansur RB; McIntyre RS; Rosenblat JD
    Psychiatry Res; 2023 Nov; 329():115531. PubMed ID: 37844352
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Epileptic versus neuro-oncological focus of management in pediatric patients with concurrent primary brain lesion and seizures: a systematic review.
    Gruber MD; Pindrik J; Damante M; Schulz L; Shaikhouni A; Leonard JR
    J Neurosurg Pediatr; 2023 Nov; 32(5):576-583. PubMed ID: 37728409
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
    Schoenfeld DA; Moutafi M; Martinez S; Djureinovic D; Merkin RD; Adeniran A; Braun DA; Signoretti S; Choueiri TK; Parisi F; Hurwitz M; Rimm DL; Wei W; Jilaveanu L; Kluger HM
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586773
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chemical modification of curcumin increases its potency against hypopharyngeal carcinoma.
    Zhang L; Cheng L; Chen Z; Fang Y; Li C; Chen M; He P; Wu H; Wu J; Chen J
    J Drug Target; 2023 Sep; 31(8):867-877. PubMed ID: 37577780
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Lactate-induced up-regulation of PLEKHA4 promotes proliferation and apoptosis of human glioma cells].
    Ye J; Xu W; Xi B; Wang N; Chen T
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1071-1080. PubMed ID: 37488789
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Quercetin induces MGMT
    Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
    Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
    van Schie P; Rijksen BLT; Bot M; Wiersma T; Merckel LG; Brandsma D; Compter A; de Witt Hamer PC; Post R; Borst GR
    J Neurooncol; 2023 Jun; 163(2):345-354. PubMed ID: 37266846
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors.
    Biswas A; Salvucci M; Connor K; Düssmann H; Carberry S; Fichtner M; King E; Murphy B; O'Farrell AC; Cryan J; Beausang A; Heffernan J; Cremona M; Hennessy BT; Clerkin J; Sweeney KJ; MacNally S; Brett F; O'Halloran P; Bacon O; Furney S; Verreault M; Quissac E; Bielle F; Ahmed MH; Idbaih A; Leenstra S; Ntafoulis I; Fabro F; Lamfers M; Golebiewska A; Hertel F; Niclou SP; Yen RTC; Kremer A; Dilcan G; Lodi F; Arijs I; Lambrechts D; Purushothama MK; Kel A; Byrne AT; Prehn JHM
    J Neurooncol; 2023 Jun; 163(2):327-338. PubMed ID: 37237151
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Crohn's disease and breast cancer: a literature review of the mechanisms and treatment.
    Zhou S; Yu J
    Intern Emerg Med; 2023 Aug; 18(5):1303-1316. PubMed ID: 37138170
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination of SIX4-siRNA and temozolomide inhibits the growth and migration of A-172 glioblastoma cancer cells.
    Mohammadpour ZJ; Mohammadzadeh R; Javadrashid D; Baghbanzadeh A; Doustvandi MA; Barpour N; Baradaran B
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2741-2751. PubMed ID: 37093251
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
    Chamorro DF; Cardona AF; Rodríguez J; Ruiz-Patiño A; Arrieta O; Moreno-Pérez DA; Rojas L; Zatarain-Barrón ZL; Ardila DV; Viola L; Recondo G; Blaquier JB; Martín C; Raez L; Samtani S; Ordóñez-Reyes C; Garcia-Robledo JE; Corrales L; Sotelo C; Ricaurte L; Cuello M; Mejía S; Jaller E; Vargas C; Carranza H; Otero J; Archila P; Bermudez M; Gamez T; Russo A; Malapelle U; de Miguel Perez D; de Lima VCC; Freitas H; Saldahna E; Rolfo C; Rosell R;
    Target Oncol; 2023 May; 18(3):425-440. PubMed ID: 37017806
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Destruction of the cellular antioxidant pool contributes to resveratrol-induced senescence and apoptosis in lung cancer.
    Liang C; Yi K; Zhou X; Li X; Zhong C; Cao H; Xie C; Zhu J
    Phytother Res; 2023 Jul; 37(7):2995-3008. PubMed ID: 36866538
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anticancer Mechanism of Flavonoids on High-Grade Adult-Type Diffuse Gliomas.
    Wong SC; Kamarudin MNA; Naidu R
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839156
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.